Codeine Market Predicted to Grow at a Moderate Pace Through 2026

Codeine Market Scrutinized in New Research 20182026
Codeine Market, by Indication (Pain Management, and Cough Management), by
Age Group (Adult and Pediatric), by Dosage Form (Tablet, Capsule and
Solution/Syrup), by Distribution Channel (Hospital Pharmacies, Retail
Pharmacies, and Online Pharmacies) and by Region (North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook,
and Opportunity Analysis, 2018 – 2026
Codeine is a drug of class known as opioids, widely used in the treatment and management of mild to
moderate pain, severe pain, dry irritating cough, diarrhea, and cold and flu (when combined with
antihistamines and decongestants). Opioids interact with opioid receptors in the brain and induce
effects such as pain relief, relaxation, pleasure, and contentment. Codeine is usually swallowed and
comes in different forms, including tablets, capsules, and solutions/syrups. Click To Read More On
Codeine Market.
Market Drivers
Codeine is widely used in the treatment and management of pain and cough. High prevalence of pain
due to increasing ageing population in key regions such as North America, and Asia- Pacific is
expected to significantly increase demand for codeine formulation and drive global codeine market
growth over the forecast period.
For instance, according to the data published by National Health Interview Survey (NHIS) in 2016, it
was estimated that around 20.4% (50.0 million) of the adults in the U.S. are suffering from chronic pain
and around 8.0% of adults in the U.S. (19.6 million) had high impact chronic pain.
According to a study published by the National Centre for Biotechnology Information (NCBI) in 2015,
around 19.6% of the individuals aged between 20 to 60 years were suffering from low back pain
worldwide.
Codeine Market Regional Analysis
North America codeine market is expected to hold a dominant position in the global codeine market
and to account for largest market share over the forecast period, owing to high presence of key players
in the region and approval and launch of novel products by them in the region.
For instance, in 2015, Tris Pharma, Inc. received U.S. Food and Drug Administration approval and
launched its Tuzistra XR (codeine polistirex and chlorpheniramine polistirex), extended-release oral
suspension, CIII (DEA Schedule III) in the U.S. market. Tuzistra XR is indicated for the treatment and
relief of cough and symptoms associated with upper respiratory allergies or a common cold in adults
aged 18 years and older.
Codeine Market Restraint
Stringent regulations in key regions for codeine formulation is expected to be a major factor restraining
growth of the codeine market in the near future. For instance, in February 2018, The Therapeutic
Goods Administration reclassified codeine as prescription only medicine in Australia, which was
previously available as over-the-counter medication. The fact behind this reclassification was that
regular use of medicines containing codeine may lead to its addiction.
Similarly, Health Canada also proposed to ban non-prescription codeine sales in 2017. Reclassification
of codeine to prescription drugs is expected to hinder its sales and adoption and is expected to restrain
the global codeine market growth over the forecast period.
Codeine Market Key Players
Key players operating in global codeine market include: Nexgen Pharma, Inc., Teva Pharmaceutical
Industries Ltd., Wraser Pharmaceuticals LLC, Larken Laboratories, Inc., Aurobindo Pharma Limited,
Sun Pharmaceutical Industries Limited, Tris Pharma Inc., and Johnson & Johnson.
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/2297
Codeine Market Taxonomy:
The global codeine market is segmented on the basis of indication, age group, dosage form, distribution
channel, and region
By Indication•Pain Management
•Cough Management
By Age Group
•Pediatric
•Adults
By Dosage Form•Tablet
•Capsule
•Solution/Syrup
By Distribution Channel•Hospitals Pharmacies
•Retail Pharmacies
•Online pharmacies
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

Codeine is a drug of class known as opioids, widely used in the treatment and management of mild to moderate pain, severe pain, dry irritating cough, diarrhea, and cold and flu (when combined with antihistamines and decongestants).

Download Report